tiprankstipranks
Amplia Therapeutics Ltd. (INNMF)
OTHER OTC:INNMF

Compare Amplia Therapeutics (INNMF) vs. Competitors

19 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Amplia Therapeutics
$0.09
$61.37M
-3.83
197.87%
Tryptamine Therapeutics
AU$48.52M
-9.56
3.45%
Neuren Pharmaceuticals Limited
AU$13.00
AU$1.65B
78.41
39.94%
6 Buy
0 Hold
0 Sell
Strong Buy
Paradigm Biopharmaceuticals
AU$0.33
AU$101.65M
-1.51
-25.00%
Alterity Therapeutics
AU$0.01
AU$108.75M
-2.12
0.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Zelira Therapeutics
AU$0.34
AU$5.95M
-1.39
0.00%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INNMF
Amplia Therapeutics
0.14
0.09
197.87%
AU:ENP
Tryptamine Therapeutics
0.03
<0.01
3.45%
AU:NEU
Neuren Pharmaceuticals Limited
13.00
3.43
35.84%
AU:PAR
Paradigm Biopharmaceuticals
0.23
-0.08
-26.23%
AU:ATH
Alterity Therapeutics
0.01
0.00
0.00%
AU:ZLD
Zelira Therapeutics
0.50
0.03
6.38%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts